Fear can lead to anxiety and depression, which can take a toll on someone’s mental well-being.
Health
Roux Institute students help Maine’s air ambulance service respond to emergencies faster
The Portland graduate students analyzed data from LifeFlight to see where it could cut down the time it takes to get in the air.
Last year, Maine made assaulting an emergency medical worker a felony. The problem of patient violence remains
Prior to the new law, health care workers filed 167 intentional injury lost time claims in the first 7 months of 2023; 114 were filed in the first 4 months after the law took effect.
A 13-year-old Bingham girl has been stuck in the ER since Christmas. She just wants a place to call home.
Her parents, hospital officials, advocates and state officials want to find a placement, but there’s no place else to go.
Republicans move at Trump’s behest to change how they will oppose abortion
The scaled-down platform reflects a desire by the Trump campaign to avoid giving Democrats more material for their warnings about the former president’s intentions if he wins back the White House.
Maine has no testing requirement for medical cannabis. Public health advocates want that to change.
As new legislation regulating marijuana takes effect, the debate about whether and how to mandate testing and potency limits for medical cannabis continues.
A bench and a grandmother’s ear: Zimbabwe’s novel mental health therapy spreads overseas
In Zimbabwe, talk therapy involving park benches and a network of grandmothers has become a saving grace for people with mental health issues
Maine announces resource center to aid local opioid settlement spending
The attorney general’s office is putting nearly $2.5 million toward a hub that will offer assistance to Maine counties, cities and towns as they decide how to spend opioid settlement funds.
Ozempic linked to rare cases of vision loss in Harvard study
The stroke-like eye condition appears to be more common in people taking new drugs for weight loss and diabetes.
U.S. will pay Moderna $176 million to develop mRNA pandemic flu vaccine
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine